344 related articles for article (PubMed ID: 36014390)
1. Recent Overview of Resveratrol's Beneficial Effects and Its Nano-Delivery Systems.
Bohara RA; Tabassum N; Singh MP; Gigli G; Ragusa A; Leporatti S
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014390
[TBL] [Abstract][Full Text] [Related]
2. The Pharmacological Properties of Red Grape Polyphenol Resveratrol: Clinical Trials and Obstacles in Drug Development.
Farhan M; Rizvi A
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892561
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and bioavailability of trans-resveratrol.
Wenzel E; Somoza V
Mol Nutr Food Res; 2005 May; 49(5):472-81. PubMed ID: 15779070
[TBL] [Abstract][Full Text] [Related]
4. Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity.
Doré S
Neurosignals; 2005; 14(1-2):61-70. PubMed ID: 15956815
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol's Potential in the Adjunctive Management of Cardiovascular Disease, Obesity, Diabetes, Alzheimer Disease, and Cancer.
Kulashekar M; Stom SM; Peuler JD
J Am Osteopath Assoc; 2018 Sep; 118(9):596-605. PubMed ID: 30178049
[TBL] [Abstract][Full Text] [Related]
6. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
Neves AR; Lúcio M; Martins S; Lima JL; Reis S
Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
[TBL] [Abstract][Full Text] [Related]
7. Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.
Gambini J; Inglés M; Olaso G; Lopez-Grueso R; Bonet-Costa V; Gimeno-Mallench L; Mas-Bargues C; Abdelaziz KM; Gomez-Cabrera MC; Vina J; Borras C
Oxid Med Cell Longev; 2015; 2015():837042. PubMed ID: 26221416
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in nanotechnology-based drug carriers for resveratrol delivery.
Li C; Wang Z; Lei H; Zhang D
Drug Deliv; 2023 Dec; 30(1):2174206. PubMed ID: 36852655
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol: a multitargeted agent for age-associated chronic diseases.
Harikumar KB; Aggarwal BB
Cell Cycle; 2008 Apr; 7(8):1020-35. PubMed ID: 18414053
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?
Weiskirchen S; Weiskirchen R
Adv Nutr; 2016 Jul; 7(4):706-18. PubMed ID: 27422505
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol still has something to say about aging!
Quideau S; Deffieux D; Pouységu L
Angew Chem Int Ed Engl; 2012 Jul; 51(28):6824-6. PubMed ID: 22730253
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol: A Double-Edged Sword in Health Benefits.
Salehi B; Mishra AP; Nigam M; Sener B; Kilic M; Sharifi-Rad M; Fokou PVT; Martins N; Sharifi-Rad J
Biomedicines; 2018 Sep; 6(3):. PubMed ID: 30205595
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanism of Resveratrol's Lipid Membrane Protection.
Fei Q; Kent D; Botello-Smith WM; Nur F; Nur S; Alsamarah A; Chatterjee P; Lambros M; Luo Y
Sci Rep; 2018 Jan; 8(1):1587. PubMed ID: 29371621
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol: review on therapeutic potential and recent advances in drug delivery.
Pangeni R; Sahni JK; Ali J; Sharma S; Baboota S
Expert Opin Drug Deliv; 2014 Aug; 11(8):1285-98. PubMed ID: 24830814
[TBL] [Abstract][Full Text] [Related]
15. The biological responses to resveratrol and other polyphenols from alcoholic beverages.
Brown L; Kroon PA; Das DK; Das S; Tosaki A; Chan V; Singer MV; Feick P
Alcohol Clin Exp Res; 2009 Sep; 33(9):1513-23. PubMed ID: 19519720
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of resveratrol in Alzheimer's disease.
Vingtdeux V; Dreses-Werringloer U; Zhao H; Davies P; Marambaud P
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S6. PubMed ID: 19090994
[TBL] [Abstract][Full Text] [Related]
17. Relaxant and antioxidant capacity of the red wine polyphenols, resveratrol and quercetin, on isolated mice corpora cavernosa.
Boydens C; Pauwels B; Decaluwé K; Brouckaert P; Van de Voorde J
J Sex Med; 2015 Feb; 12(2):303-12. PubMed ID: 25443137
[TBL] [Abstract][Full Text] [Related]
18. In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant.
Chen WP; Su MJ; Hung LM
Eur J Pharmacol; 2007 Jan; 554(2-3):196-204. PubMed ID: 17107672
[TBL] [Abstract][Full Text] [Related]
19. Biological actions and molecular effects of resveratrol, pterostilbene, and 3'-hydroxypterostilbene.
Tsai HY; Ho CT; Chen YK
J Food Drug Anal; 2017 Jan; 25(1):134-147. PubMed ID: 28911531
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol and cardiovascular system-the unfulfilled hopes.
Chudzińska M; Rogowicz D; Wołowiec Ł; Banach J; Sielski S; Bujak R; Sinkiewicz A; Grześk G
Ir J Med Sci; 2021 Aug; 190(3):981-986. PubMed ID: 33219913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
